» Cancer Insurance » Molecular Diagnostics In Cancer Testing

Molecular Diagnostics In Cancer Testing

Molecular Diagnostics in Cancer Testing

Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added. The technologies that come under the umbrella of molecular diagnostics include first-generation amplification, DNA probes, fluorescent in-situ hybridization (FISH), second-generation biochips and microfluidics, next-generation signal detection, biosensors and molecular labels, and gene expression profiling using microarrays. ( )

These technologies are improving the discovery of therapeutic molecules for cancer, the screening, diagnosis and classification of cancer patients, and the optimization of drug therapy. This report describes the specific segment of the in vitro diagnostics (IVD) market known as molecular diagnostics (MD), with a specialization in the MD tests for cancer. In the current medical diagnostics market, molecular diagnostics for cancer testing offers one of the brightest areas for growth and innovation. The confluence of breakthroughs in genomics, proteomics, and the development of microarray devices to measure analytes in the blood and various body tissues, has led to this revolutionary market segment offering the power of advanced analytical techniques to the diagnosis and treatment of cancer. This report analyzes the size and growth of the molecular diagnostics market in its applications for cancer detection and therapy, examining the factors that influence the various market segments and the dollar volume of sales, both in the United States and worldwide.

Key Chapters of the report :

1. Overview 6

1.1 Statement of Report 6

1.2 About This Report 6

1.3 Scope of the Report 7

1.4 Objectives 7

1.5 Methodology 8

1.6 Executive Summary 9

2. Introduction to Molecular Diagnostics 13

2.1 Opening Up of Opportunities in Molecular Diagnostics 13

2.2 Impact of the Human Genome Project on Molecular Diagnostics 15

2.3 Considerations for Molecular and Clinical Diagnostics 16

2.4 Molecular Diagnostics in the Post-Genomic Era 19

2.5 Advances in Molecular Diagnostics Technologies 20

2.6 Oligonucleotide Array Platforms 21

2.7 Emerging Cancer Personalized Medicine Market 22

2.8 Companion Tests for Drug Development 24

3. Cancer Diagnostics Molecular Testing Market 27

3.1 Market Description 30

3.1.1 Market Overview 30

3.1.2 Tumor Markers 31

3.1.3 Molecular Diagnostic Markers 39

3.1.4 Competitive Landscape 40

To know more and to buy a copy of your report feel free to visit :


Contact us at :

Bharat Book Bureau

Tel: +91 22 27578668

Fax: +91 22 27579131




Follow us on twitter:

by: bharat book bureau guest:  register | login | search     IP( England / Spalding Processed in 0.017152 second(s), 5 queries , Gzip enabled debug code: 72 , 3276, 301,
Molecular Diagnostics In Cancer Testing Spalding